Form 4: Pfizer SVP & Controller Sells Shares for Tax Obligations
Insider Transaction Report
Pfizer's SVP & Controller, Jennifer B. Damico, disposed of 419 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Jennifer B. Damico, Senior Vice President & Controller of Pfizer Inc. (PFE), reported a transaction involving company common stock.
- On February 23, 2026, Damico disposed of 419 shares of Pfizer Common Stock.
- The disposition was made at a price of $27.06 per share.
- This transaction (Code 'F') represents the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units, including dividend equivalents.
- Following this transaction, Damico beneficially owns 12,186 shares of Pfizer Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine tax-related disposition of shares upon vesting of restricted stock units and does not reflect a discretionary sale or a change in the company's operational or financial outlook.
Industry Context
StockSavvy.ai notes that this type of transaction, involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units, is a routine and common occurrence for executives receiving equity compensation across various industries. It is a standard mechanism for managing tax liabilities associated with equity awards.
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 02/23/2026 | Date of transaction (disposition of shares) |
| 02/24/2026 | Date the Form 4 was signed and filed |
Recommendation
holdThis Form 4 reports a routine disposition of shares to cover tax obligations upon the vesting of restricted stock units. Such transactions are common for executives and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation.
Keywords
Pfizer, PFE, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.